BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6330664)

  • 1. The stimulatory effect of a non-opiate beta-endorphin fragment on arginine-vasopressin release in rats.
    Laczi F; Sykes JE; Wiegant VM; de Wied D
    Acta Med Hung; 1984; 41(1):55-63. PubMed ID: 6330664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Endorphin secretion of arginine vasopressin in vivo.
    Weitzman RE; Fisher DA; Minick S; Ling N; Guillemin R
    Endocrinology; 1977 Nov; 101(5):1643-6. PubMed ID: 913330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced activity of the beta-endorphinergic system in the anterior and neurointermediate lobe of the rat pituitary after chronic treatment with ethanol liquid diet.
    Seizinger BR; Bovermann K; Höllt V; Herz A
    J Pharmacol Exp Ther; 1984 Aug; 230(2):455-61. PubMed ID: 6086890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phencyclidine increased release of beta-endorphin from anterior lobe of the pituitary.
    Contreras PC; Jacobson AE; Rice KC; Farah JM
    J Pharmacol Exp Ther; 1991 Sep; 258(3):837-41. PubMed ID: 1653842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of beta-endorphin in the deteriorating effect of arginine vasopressin on burn shock in rats.
    Sun K; Lin BC; Zhang C; Wang CH; Zhu HN
    Circ Shock; 1989 Nov; 29(3):167-74. PubMed ID: 2591029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early polyuria in the rat following single-dose cis-dichlorodiammineplatinum (II): effects on plasma vasopressin concentration and posterior pituitary function.
    Clifton GG; Pearce C; O'Neill WM; Wallin JD
    J Lab Clin Med; 1982 Nov; 100(5):659-70. PubMed ID: 6890090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenergic control of immunoreactive beta-endorphin release from the pituitary of the rat: in vitro and in vivo studies.
    Pettibone DJ; Mueller GP
    J Pharmacol Exp Ther; 1982 Jul; 222(1):103-8. PubMed ID: 6283065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional aspects of endorphins.
    Herz A; Höllt V; Przewłocki R; Osborne H; Gramsch C; Duka T
    Prog Biochem Pharmacol; 1980; 16():11-21. PubMed ID: 7443728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pituitary beta-endorphin secretagogues on the concentration of beta-endorphin in rat cerebrospinal fluid: evidence for a role of vasopressin in the regulation of brain beta-endorphin release.
    Barna I; Sweep CG; Veldhuis HD; Wiegant VM; De Wied D
    Neuroendocrinology; 1990 Jan; 51(1):104-10. PubMed ID: 2137562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of beta-endorphin-immunoreactivity from rat pituitary and hypothalamus in vitro: effects of isoproterenol, dopamine, corticotropin-releasing factor and arginine8-vasopressin.
    Sweep CG; Wiegant VM
    Biochem Biophys Res Commun; 1989 May; 161(1):221-8. PubMed ID: 2525039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine vasopressin induces periaqueductal gray release of enkephalin and endorphin relating to pain modulation in the rat.
    Yang J; Yang Y; Xu HT; Chen JM; Liu WY; Lin BC
    Regul Pept; 2007 Jul; 142(1-2):29-36. PubMed ID: 17341433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the opioid peptide beta-endorphin on the in vivo release of vasopressin in rats under various conditions.
    ten Haaf JA; van Wimersma Greidanus TB; Maigret C; De Wied D
    Neuroendocrinology; 1986; 44(1):102-7. PubMed ID: 2946974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M; Cover PO; Poyser RH; Buckingham JC
    Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoproterenol-stimulated release of beta-endorphin and related peptides from the rat pituitary neurointermediate lobe in vitro: evidence for preferential release of certain molecular forms of beta-endorphin.
    Sweep CG; Boersma CJ; Wiegant VM
    Neuropeptides; 1990 Oct; 17(2):63-73. PubMed ID: 2280822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of gamma-type endorphins on alpha-MSH release in the rat.
    de Rotte AA; van Wimersma Greidanus TB; van de Buuse M; Andringa-Bakker EA; de Wied D
    Life Sci; 1985 Jul; 37(3):263-71. PubMed ID: 2409428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The concentration of arginine vasopressin in pituitary stalk plasma of the rat after adrenalectomy or morphine.
    Koenig JI; Meltzer HY; Devane GD; Gudelsky GA
    Endocrinology; 1986 Jun; 118(6):2534-9. PubMed ID: 2938937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin enhances the clearance of beta-endorphin immunoreactivity from rat cerebrospinal fluid.
    Sweep CG; Boomkamp MD; Barna I; Logtenberg AW; Wiegant VM
    Acta Endocrinol (Copenh); 1990 Feb; 122(2):191-200. PubMed ID: 2138399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous measurement of arginine vasopressin and oxytocin in plasma and neurohypophyses by radioimmunoassay.
    Landgraf R
    Endokrinologie; 1981 Dec; 78(2-3):191-204. PubMed ID: 7333224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of beta-endorphin2-9 on arginine-8-vasopressin and oxytocin levels in hypothalamic and limbic brain regions.
    Laczi F; Vecsernyés M; Kovács GL; Szabó G; Janáky T; Telegdy G; Lásló FA
    Brain Res; 1987 Feb; 403(1):155-7. PubMed ID: 3828809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of the neurohypophysis in psychological stress].
    Scantamburlo G; Ansseau M; Legros JJ
    Encephale; 2001; 27(3):245-59. PubMed ID: 11488255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.